Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Organ Transplantation, Ministry of Education, Wuhan, China; NHC Key Laboratory of Organ Transplantation, Wuhan, China; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.
Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Asian J Surg. 2024 Jun;47(6):2625-2631. doi: 10.1016/j.asjsur.2024.03.001. Epub 2024 Mar 29.
Ex vivo liver resection and autotransplantation (ERAT) can be used to treat locally advanced tumors that are conventionally unresectable. Because the procedure is rare, there are very few reports in the literature. Recently, we performed ERAT for two cases of cholangiocarcinoma invading caudate lobe, the retrohepatic vena cava and hepatic veins, and investigated technical variations of this procedure.
One patient was a 57-year-old man with liver caudate lobe metastasis from cholangiocarcinoma after pancreaticoduodenal resection five years ago, and the other patient was a 68-year-old man with caudate lobe cholangiocarcinoma. Both cases were considered to be unresectable by conventional resection due to the critical invasion of the retrohepatic vena cava along with the three hepatic veins. Therefore, ERAT was indicated in these two cases.
The liver along with the retrohepatic vena cava was removed, which was replaced by GORE-TEX synthetic artificial vessel grafts with angioplasty to reconstruct the inferior vena cava (IVC), and the GORE-TEX synthetic artificial vessel anastomosed to the right auricular appendage or the IVC to build the continuity of the IVC. Ex vivo caudate lobe hepatectomy was performed, along with the retrohepatic vena cava and hepatic veins, and subsequently the reconstruction outflow of hepatic venous was established using cold-preserved allogeneic vessels and falciform ligament. Finally, remnant of the liver was implanted by Piggyback liver transplantation. The hepatic vein, portal vein, hepatic artery and bile duct were anastomosed, and autotransplantation of the liver was completed. The patients were followed-up for 18 months and showed good liver function, with no recurrence of cancer.
ERAT should be considered as a therapeutic option for selected patients with cholangiocarcinoma invading caudate lobe, the retrohepatic vena cava and hepatic veins. It is crucial to reconstruct the outflow of hepatic venous according to different situations.
离体肝切除和自体肝移植(ERAT)可用于治疗传统上无法切除的局部晚期肿瘤。由于该手术较为罕见,因此文献报道很少。最近,我们对 2 例侵犯尾状叶、肝后下腔静脉和肝静脉的胆管癌患者进行了 ERAT,并对该手术的技术变化进行了研究。
1 例患者为 57 岁男性,胰十二指肠切除术后 5 年因肝尾状叶转移而患有胆管癌;另 1 例患者为 68 岁男性,患有尾状叶胆管癌。由于肝后下腔静脉和三条肝静脉严重受累,常规切除被认为无法切除,因此这两例患者均适合 ERAT。
切除肝和肝后下腔静脉,用 Gore-Tex 合成人工血管移植物进行血管成形术重建下腔静脉(IVC),将 Gore-Tex 合成人工血管与右心耳或 IVC 吻合,建立 IVC 的连续性。进行离体尾状叶肝切除术,切除肝后下腔静脉和肝静脉,然后用冷保存同种异体血管和镰状韧带建立肝静脉流出重建。最后,采用背驮式肝移植将剩余肝脏植入。肝静脉、门静脉、肝动脉和胆管吻合,完成肝自体移植。两名患者均随访 18 个月,肝功能良好,无癌症复发。
ERAT 应被视为治疗侵犯尾状叶、肝后下腔静脉和肝静脉的胆管癌的一种治疗选择。根据不同情况重建肝静脉流出是至关重要的。